
AI in MedTech: We need to strike the right balance between innovation and regulation
Stricter regulation is inevitable, so how should Medtech companies react? By Cognizant’s Rohit Alimchandani
Back to Top
Stricter regulation is inevitable, so how should Medtech companies react? By Cognizant’s Rohit Alimchandani
Diane Bullman reveals the difference mentoring made to this year’s participants and looks ahead to the 2025 programme – which includes a new stream run
Clinicians need a culture of education and understanding to get the best out of AI and protect themselves and their patients from inappropriate information, writes
As a service, pharmacy dislikes change, preferring to apply ‘band-aids’ to traditional systems. But the advantages of digitising are now too great to ignore, writes
Digital Health’s Advisory Panel invited members of the Shuri Network to join the panel last year. For Vicki Kong and Elohor Uwadiogbu it was a
Appropriate engagement and support for clinical staff is not just fundamental to digital implementation, it
Concerns about AI should not stop progress. They should prompt us to think about how
Building a ‘superapp’ is a delicate act of statecraft, writes Mohammad Al Ubaydli from Patients
The major parties see a big role for tech in easing pressure on the NHS
In 2016 a CCIO network survey revealed that only 44% of CCIOs had the authority